RNA Interference for Viral Infections

Stephen Blake, Fawzi F. Bokhari, Nigel A.J. McMillan

Research output: Contribution to journalReview article

14 Citations (Scopus)

Abstract

The treatment of viral infections has relied on pre-emptive vaccination or use of a limited range of anti-viral drugs. However, the majority of viruses have no available drugs and treatment is merely supportive. RNA interference (RNAi) offers the ability to directly and rapidly treat virus infections via the targeting of viral genes. Indeed, clinical trials have already been undertaken with promising results. Here we review the current state of the RNAi field for the treatment of viral infections such as HIV, human papillomavirus and HCV. We also review novel strategies including the concept of targeting self-genes to limit viral infection and activating the immune system for improved outcomes. Finally we examine innovative approaches being pursued at the Australian Infectious Diseases Research Centre including the use of highthroughput siRNA screens to identify new antiviral targets.

Original languageEnglish
Pages (from-to)1411-1420
Number of pages10
JournalCurrent Drug Targets
Volume13
Issue number11
DOIs
Publication statusPublished - 5 Oct 2012
Externally publishedYes

Keywords

  • HCV
  • HIV
  • HPV
  • RNA interference
  • Screening

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry

Cite this